Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Norwegian (OSEAX) Pharma Industry Analysis

UpdatedApr 17, 2025
DataAggregated Company Financials
Companies5
  • 7D10.0%
  • 3M-2.8%
  • 1Y-16.5%
  • YTD-8.0%

Last week, the Pharma industry hasn't moved much but Photocure is up 12% in that time. Unfortunately though, the industry is down 20% over the past 12 months. As for the next few years, earnings are expected to grow by 72% per annum.

Industry Valuation and Performance

Has the Norwegian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 17 Apr 2025NOK 3.2bNOK 1.5b-NOK 129,957,000.00141.3x-24.5x2.1x
Sat, 15 Mar 2025NOK 3.1bNOK 1.5b-NOK 153,695,743.00150.2x-20.4x2.1x
Mon, 10 Feb 2025NOK 3.3bNOK 1.5bNOK 22.4m22x148.7x2.3x
Wed, 08 Jan 2025NOK 3.1bNOK 1.5bNOK 22.4m23x138.9x2.1x
Fri, 06 Dec 2024NOK 2.9bNOK 1.5bNOK 22.4m21.6x129.2x2x
Sun, 03 Nov 2024NOK 3.0bNOK 1.5bNOK 34.2m21.4x88.6x2.1x
Tue, 01 Oct 2024NOK 3.3bNOK 1.5bNOK 45.2m21.7x73.1x2.2x
Thu, 29 Aug 2024NOK 2.9bNOK 1.5bNOK 105.8m20.4x27.3x1.9x
Sat, 27 Jul 2024NOK 3.0bNOK 1.5bNOK 49.7m159.8x60x2x
Mon, 24 Jun 2024NOK 3.3bNOK 1.5bNOK 10.2m181.6x323.6x2.2x
Wed, 22 May 2024NOK 3.2bNOK 1.5bNOK 7.6m175.1x427x2.2x
Fri, 19 Apr 2024NOK 3.2bNOK 1.5bNOK 7.6m153.1x421.3x2.2x
Sun, 17 Mar 2024NOK 3.2bNOK 1.5bNOK 33.1m153.3x97.1x2.2x
Tue, 13 Feb 2024NOK 3.4bNOK 1.4bNOK 18.6m25.5x183.1x2.4x
Thu, 11 Jan 2024NOK 3.6bNOK 1.4bNOK 18.6m25.4x195.1x2.6x
Sat, 09 Dec 2023NOK 3.3bNOK 1.4bNOK 18.6m24.7x178.2x2.3x
Mon, 06 Nov 2023NOK 3.3bNOK 1.4b-NOK 8,236,125.0027.6x-398.7x2.4x
Wed, 04 Oct 2023NOK 3.2bNOK 1.3b-NOK 38,433,125.0053.4x-83.2x2.4x
Fri, 01 Sep 2023NOK 2.9bNOK 1.3b-NOK 53,836,125.0048.1x-53.4x2.1x
Sun, 30 Jul 2023NOK 3.0bNOK 1.2b-NOK 60,357,125.0078.4x-50.1x2.4x
Tue, 27 Jun 2023NOK 3.0bNOK 1.2b-NOK 60,357,125.0076.3x-49.9x2.4x
Thu, 25 May 2023NOK 3.2bNOK 1.2b-NOK 104,503,000.0076.5x-30.3x2.6x
Sat, 22 Apr 2023NOK 3.0bNOK 1.1b-NOK 140,813,000.0022x-21.3x2.8x
Mon, 20 Mar 2023NOK 3.3bNOK 1.1b-NOK 140,813,000.0023.4x-23.7x3.1x
Wed, 15 Feb 2023NOK 4.6bNOK 1.0b-NOK 148,546,289.0047x-31.1x4.5x
Fri, 13 Jan 2023NOK 4.7bNOK 1.0b-NOK 148,546,289.0046.2x-31.4x4.6x
Sun, 11 Dec 2022NOK 4.5bNOK 1.0b-NOK 148,546,289.0048.4x-30x4.4x
Tue, 08 Nov 2022NOK 4.4bNOK 1.0b-NOK 148,546,289.0049.2x-29.4x4.3x
Thu, 06 Oct 2022NOK 3.8bNOK 940.6m-NOK 141,575,289.0080.7x-26.7x4x
Sat, 03 Sep 2022NOK 4.0bNOK 940.6m-NOK 141,575,289.0072x-28.4x4.3x
Mon, 01 Aug 2022NOK 4.4bNOK 885.3m-NOK 151,605,000.00466.6x-28.9x5x
Wed, 29 Jun 2022NOK 4.4bNOK 922.8m-NOK 127,667,000.0082.4x-34.1x4.7x
Fri, 27 May 2022NOK 4.5bNOK 922.8m-NOK 127,667,000.0080.1x-34.9x4.8x
Sun, 24 Apr 2022NOK 4.7bNOK 925.5m-NOK 91,613,000.00403.1x-51.7x5.1x
Price to Earnings Ratio

-51.7x


Total Market Cap: NOK 4.7bTotal Earnings: -NOK 91,613,000.00Total Revenue: NOK 925.5mTotal Market Cap vs Earnings and Revenue0%0%0%
Norwegian Pharma Industry Price to Earnings3Y Average 41.7x202320242025
Current Industry PE
  • Investors are pessimistic on the Norwegian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 2.9x is higher than the industry's current PS ratio of 2.1x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 17% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the Norwegian Healthcare industry?

NO Market5.98%
Healthcare3.34%
Pharma10.00%
Pharma10.00%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PHO PhotocureNOK 54.2012.0%
+NOK 154.3m		0.7%PS2.7x
ONCIN OncoinventNOK 1.9932.9%
+NOK 48.3m		n/aPS71.4x
VISTN Vistin PharmaNOK 24.004.3%
+NOK 44.3m		0%PE17x
NAVA NavamedicNOK 19.406.9%
+NOK 22.1m		-42.6%PE265.6x
SOFTX SoftOx SolutionsNOK 0.06416.8%
+NOK 20.6m		-70.9%PS18.1x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

PHO

NOK 54.20

Photocure

7D

12.0%

1Y

0.7%

NAVA

NOK 19.40

Navamedic

7D

6.9%

1Y

-42.6%

ONCIN

NOK 1.99

Oncoinvent

7D

32.9%

1Y

n/a

VISTN

NOK 24.00

Vistin Pharma

7D

4.3%

1Y

0%

Vistin Pharma's (OB:VISTN) Upcoming Dividend Will Be Larger Than Last Year's

Feb 16
Vistin Pharma's (OB:VISTN) Upcoming Dividend Will Be Larger Than Last Year's

SOFTX

NOK 0.064

SoftOx Solutions

7D

16.8%

1Y

-70.9%